AVIR Archived Articles
Atea Pharmaceuticals (AVIR): Positioning for Success in the Competitive Hepatitis C Landscape
Published on March 12, 2025
Atea Pharmaceuticals (AVIR): Navigating the Evolving Landscape of Antiviral Therapeutics
Published on November 27, 2024
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR): Advancing Promising Antiviral Candidates for COVID-19 and Hepatitis C
Published on September 24, 2024